Barcellini L, Nardin S, Sacco G, Ferrante M, Rossi G, Barletta G
Cancers (Basel). 2025; 17(4).
PMID: 40002247
PMC: 11853691.
DOI: 10.3390/cancers17040652.
Seyedi S, Harris V, Kapsetaki S, Narayanan S, Saha D, Compton Z
Cancer Res. 2024; 84(22):3715-3727.
PMID: 39356625
PMC: 11565176.
DOI: 10.1158/0008-5472.CAN-23-3374.
Pandey P, Chaudhary R, Tripathi D, Lavudi K, Dua K, Weinfeld M
Med Oncol. 2024; 41(11):252.
PMID: 39320608
DOI: 10.1007/s12032-024-02504-4.
Akaike T, Thakuria M, Silk A, Hippe D, Park S, So N
J Clin Oncol. 2024; 42(26):3151-3161.
PMID: 39052958
PMC: 11379364.
DOI: 10.1200/JCO.23.02054.
De-Pieri E, Zaccaron R, Mezzari C, Cardoso M, de Roch Casagrande L, Silveira P
Immunol Res. 2024; 72(4):788-796.
PMID: 38698191
DOI: 10.1007/s12026-024-09485-6.
Precision cancer classification using liquid biopsy and advanced machine learning techniques.
Eledkawy A, Hamza T, El-Metwally S
Sci Rep. 2024; 14(1):5841.
PMID: 38462648
PMC: 10925597.
DOI: 10.1038/s41598-024-56419-1.
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
Ben-Ami R, Wang Q, Zhang J, Supplee J, Fahrmann J, Lehmann-Werman R
Gut. 2023; 73(4):639-648.
PMID: 38123998
PMC: 10958271.
DOI: 10.1136/gutjnl-2023-331074.
Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response.
Boniface C, Spellman P
Pathol Oncol Res. 2022; 28:1610103.
PMID: 35665409
PMC: 9160182.
DOI: 10.3389/pore.2022.1610103.
Liquid biopsies to occult brain metastasis.
Rehman A, Khan P, Maurya S, Siddiqui J, Santamaria-Barria J, Batra S
Mol Cancer. 2022; 21(1):113.
PMID: 35538484
PMC: 9088117.
DOI: 10.1186/s12943-022-01577-x.
Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer.
Obermayr E, Koppensteiner N, Heinzl N, Schuster E, Holzer B, Fabikan H
J Pers Med. 2021; 11(11).
PMID: 34834576
PMC: 8620949.
DOI: 10.3390/jpm11111225.
Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer.
Tsou P, Lin Z, Pan Y, Yang H, Chang C, Liang S
Cancers (Basel). 2021; 13(6).
PMID: 33801001
PMC: 8003836.
DOI: 10.3390/cancers13061431.
Emerging non-invasive detection methodologies for lung cancer.
Li Z, Shu J, Yang B, Zhang Z, Huang J, Chen Y
Oncol Lett. 2020; 19(5):3389-3399.
PMID: 32269611
PMC: 7115116.
DOI: 10.3892/ol.2020.11460.
Therapeutic Monitoring of Circulating DNA Mutations in Metastatic Cancer with Personalized Digital PCR.
Wood-Bouwens C, Haslem D, Moulton B, Almeda A, Lee H, Heestand G
J Mol Diagn. 2019; 22(2):247-261.
PMID: 31837432
PMC: 7031679.
DOI: 10.1016/j.jmoldx.2019.10.008.
Liquid biopsy in tumors: opportunities and challenges.
Bai Y, Zhao H
Ann Transl Med. 2019; 6(Suppl 1):S89.
PMID: 30613664
PMC: 6291575.
DOI: 10.21037/atm.2018.11.31.
Potent immunosuppressive effects of the oncometabolite -2-hydroxyglutarate.
Galluzzi L, Kroemer G
Oncoimmunology. 2018; 7(12):e1528815.
PMID: 30524910
PMC: 6279319.
DOI: 10.1080/2162402X.2018.1528815.
Circulating Tumor DNA Assays in Clinical Cancer Research.
Ossandon M, Agrawal L, Bernhard E, Conley B, Dey S, Divi R
J Natl Cancer Inst. 2018; 110(9):929-934.
PMID: 29931312
PMC: 6136923.
DOI: 10.1093/jnci/djy105.
